The global GI stool testing market is poised to grow with a sizable increase in the number of individuals suffering from gastrointestinal infection (GI).
The GI stool testing tools help in diagnosing various gastrointestinal diseases, so as to help the healthcare personnel in prescribing medicines for the same, and also help the research institutes to devise better versions of the existing medications.
The companies operating in the GI stool testing market are exploring gut DNA virome in the fecal immunochemical test stool samples in order to establish associations with the lifestyle in a huge population-based study.
They are also incorporating non-invasive RNA tests for colorectal cancer screening, especially the ones approved by the regulatory bodies.
A gastrointestinal infections (GI) panel tests a stool sample for simultaneously detecting bacteria, viruses, and parasites that are the common attributes to GI infections.
In other words, a stool test is referred to as a diagnostic tool used by healthcare providers to gauge the reason behind stomach issues. The healthcare providers make use of stool tests for helping in the diagnosis of colon cancer along with gastrointestinal diseases.
The ongoing trend is that of growing adoption of direct-to-customer laboratory testing such as occult and fecal blood tests like Hemoccult. Advancements in this regard include development of enhanced occult and fecal blood tests such as Hemoccult II SENSA.
Stool Sample Quantitative Collection and Extraction Device (SQED) is streamlining collection process and raising the precision quotient (PQ) of stool specimen extraction.
| Attribute | Detail |
|---|---|
| Market Drivers |
|
As per the National Institutes of Health, over 50,000 cases of gastrointestinal illness are witnessed every minute, particularly in children. It further states that the number of fatalities from diarrheal diseases alone is more than 2 million worldwide.
Majority of GI stool testing industry are caused due to viruses, with novovirus being the common one, whereas parasites and bacteria also contribute toward chronic and acute gastrointestinal infections and their sequelae.
Individuals at a higher risk of gastrointestinal infections as well as their complications are recommended to avert undercooked/raw foods from the animals, and also raw sprouts and unpasteurized dairy products. A parasitic gastrointestinal infection can be avoided by practicing good hygiene that includes hand washing.
Need to diagnose these risks as mentioned above as well as incidences of GI are thus accelerating the GI stool testing market demand.
The key participants are involved in the development of innovative test kits, thereby contributing toward market growth. For instance, in January 2023, Geneoscopy submitted premarket approval application to the U.S. FDA for stool-based colorectal cancer screening test.
The other innovative tests include developing multitarget fecal RNA and DNA assays. Such tests detect key epigenetic changes and mutations and offer improved diagnostic specificity and sensitivity.
Moreover, non-invasive testing methods such as developing at-home screening tests such as ColoClear are drawing more number of patients due to the convenience factor involved.
Efforts are being made to curtail costs of the stool DNA tests and incorporate them as point-of-care diagnostics. This initiative is expected to make the advanced DNA tests more accessible. Moreover, regulatory support along with patent grants for new stool sample collection devices such as in-situ fecal specimen sampling device presents an opportunity for growth.
Continual innovations as mentioned above are thus expanding the GI stool testing market size.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
As per the latest GI stool testing market analysis, North America dominated the stool sample analysis landscape in 2023 and the scenario is expected to persist during the forecast period. This is attributed to increase in the number of patients suffering from gastrointestinal diseases such as colorectal cancer.
As per an article published by the National Library of Medicine (NLM) in July 2022, 20% of adults in the U.S. are living with gastroesophageal reflux disease (GERD).
Moreover, according to data published by Canadian Cancer Society, colorectal cancer was the fourth most diagnosed cancer in Canada in 2022. It further specifies that 24,300 Canadians were diagnosed with colorectal cancer in 2022 alone.
Asia Pacific’s notable GI stool testing market growth is ascribed to presence of a big patient pool in the form of geriatric population coupled with noteworthy R&D activities pertaining to gastrointestinal diseases being conducted.
The key players in GI stool testing market are launching new products in order to widen their consumer base in gastrointestinal stool analysis landscape.
For instance, in June 0222, Meridian Bioscience, Inc. introduced Lyo-Ready sample-specific stool mixes with the objective of supporting diagnostic assay stabilization at room temperature for boosting molecular detection.
Abbott Laboratories, Beckman Coulter, Inc., Bio-Rad Laboratories, BioMérieux Inc., Cardinal Health, Inc., Cenogenics Corporation, Epitope Diagnostics, Inc., ScheBo Biotech AG, Quest Diagnostics, and Genova Diagnostics are some of the key players covered in the GI stool testing market report.
These companies have been profiled based on parameters such as company overview, business strategies, financial overview, product portfolio, and business segments.
| Attribute | Detail |
|---|---|
| Market Size in 2023 | US$ 555.0 Mn |
| Market Forecast (Value) in 2034 | US$ 1.3 Bn |
| Growth Rate (CAGR) | 7.7% |
| Forecast Period | 2024-2034 |
| Historical Data Available for | 2020-2022 |
| Quantitative Units | US$ Mn/Bn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available Upon Request |
| Pricing | Available Upon Request |
It was valued at US$ 555.0 Mn in 2023
It is projected to grow at a CAGR of 7.7% from 2024 to 2034
Increase in incidence of gastrointestinal infection and technological innovations in stool DNA testing
Hospitals segment accounted for the largest share in 2023
North America was the dominant region in 2023
Abbott Laboratories, Beckman Coulter, Inc., Bio-Rad Laboratories, BioMérieux Inc., Cardinal Health, Inc., Cenogenics Corporation, Epitope Diagnostics, Inc., ScheBo Biotech AG, Quest Diagnostics, and Genova Diagnostics
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global GI Stool Testing Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global GI Stool Testing Market Analysis and Forecast, 2020-2034
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global GI Stool Testing Market Analysis and Forecast, by Product Type
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product Type, 2020-2034
6.3.1. Consumables
6.3.2. Analyzers
6.4. Market Attractiveness, by Product Type
7. Global GI Stool Testing Market Analysis and Forecast, by Test Type
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Test Type, 2020-2034
7.3.1. Occult Blood Test
7.3.2. Ova and Parasites Test
7.3.3. Fecal Biomarkers Test
7.3.4. Others (Bacteria Test, etc.)
7.4. Market Attractiveness, by Test Type
8. Global GI Stool Testing Market Analysis and Forecast, by Indication
8.1. Introduction and Definitions
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Indication, 2020-2034
8.3.1. Infection
8.3.2. Inflammatory Bowel Disease
8.3.3. Gastroesophageal Reflux Disease
8.3.4. Cancer
8.3.5. Others (Poor Absorption Problems, etc.)
8.4. Market Attractiveness, by Indication
9. Global GI Stool Testing Market Analysis and Forecast, by End-user
9.1. Introduction and Definitions
9.2. Key Findings/Developments
9.3. Market Value Forecast, by End-user, 2020-2034
9.3.1. Hospitals
9.3.2. Diagnostic Centers & laboratories
9.3.3. Academic Institutes
9.3.4. Research Centers & Organizations
9.3.5. Others (Homecare Settings, etc.)
9.4. Market Attractiveness, by End-user
10. Global GI Stool Testing Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region, 2020-2034
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness, by Region
11. North America GI Stool Testing Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2020-2034
11.2.1. Consumables
11.2.2. Analyzers
11.3. Market Attractiveness, by Product Type
11.4. Market Value Forecast, by Test Type, 2020-2034
11.4.1. Occult Blood Test
11.4.2. Ova and Parasites Test
11.4.3. Fecal Biomarkers Test
11.4.4. Others (Bacteria Test, etc.)
11.5. Market Attractiveness, by Test Type
11.6. Market Value Forecast, by Indication, 2020-2034
11.6.1. Infection
11.6.2. Inflammatory Bowel Disease
11.6.3. Gastroesophageal Reflux Disease
11.6.4. Cancer
11.6.5. Others (Poor Absorption Problems, etc.)
11.7. Market Attractiveness, by Indication
11.8. Market Value Forecast, by End-user, 2020-2034
11.8.1. Hospitals
11.8.2. Diagnostic Centers & laboratories
11.8.3. Academic Institutes
11.8.4. Research Centers & Organizations
11.8.5. Others (Homecare Settings, etc.)
11.9. Market Attractiveness, by End-user
11.10. Market Value Forecast, by Country/Sub-region, 2020-2034
11.10.1. U.S.
11.10.2. Canada
11.11. Market Attractiveness Analysis
11.11.1. By Product Type
11.11.2. By Test Type
11.11.3. By Indication
11.11.4. By End-user
11.11.5. By Country
12. Europe GI Stool Testing Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2020-2034
12.2.1. Consumables
12.2.2. Analyzers
12.3. Market Attractiveness, by Product Type
12.4. Market Value Forecast, by Test Type, 2020-2034
12.4.1. Occult Blood Test
12.4.2. Ova and Parasites Test
12.4.3. Fecal Biomarkers Test
12.4.4. Others (Bacteria Test, etc.)
12.5. Market Attractiveness, by Test Type
12.6. Market Value Forecast, by Indication, 2020-2034
12.6.1. Infection
12.6.2. Inflammatory Bowel Disease
12.6.3. Gastroesophageal Reflux Disease
12.6.4. Cancer
12.6.5. Others (Poor Absorption Problems, etc.)
12.7. Market Attractiveness, by Indication
12.8. Market Value Forecast, by End-user, 2020-2034
12.8.1. Hospitals
12.8.2. Diagnostic Centers & laboratories
12.8.3. Academic Institutes
12.8.4. Research Centers & Organizations
12.8.5. Others (Homecare Settings, etc.)
12.9. Market Attractiveness, by End-user
12.10. Market Value Forecast, by Country/Sub-region, 2020-2034
12.10.1. Germany
12.10.2. U.K.
12.10.3. France
12.10.4. Italy
12.10.5. Spain
12.10.6. Rest of Europe
12.11. Market Attractiveness Analysis
12.11.1. By Product Type
12.11.2. By Test Type
12.11.3. By Indication
12.11.4. By End-user
12.11.5. By Country/Sub-region
13. Asia Pacific GI Stool Testing Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2020-2034
13.2.1. Consumables
13.2.2. Analyzers
13.3. Market Attractiveness, by Product Type
13.4. Market Value Forecast, by Test Type, 2020-2034
13.4.1. Occult Blood Test
13.4.2. Ova and Parasites Test
13.4.3. Fecal Biomarkers Test
13.4.4. Others (Bacteria Test, etc.)
13.5. Market Attractiveness, by Test Type
13.6. Market Value Forecast, by Indication, 2020-2034
13.6.1. Infection
13.6.2. Inflammatory Bowel Disease
13.6.3. Gastroesophageal Reflux Disease
13.6.4. Cancer
13.6.5. Others (Poor Absorption Problems, etc.)
13.7. Market Attractiveness, by Indication
13.8. Market Value Forecast, by End-user, 2020-2034
13.8.1. Hospitals
13.8.2. Diagnostic Centers & laboratories
13.8.3. Academic Institutes
13.8.4. Research Centers & Organizations
13.8.5. Others (Homecare Settings, etc.)
13.9. Market Attractiveness, by End-user
13.10. Market Value Forecast, by Country/Sub-region, 2020-2034
13.10.1. China
13.10.2. Japan
13.10.3. India
13.10.4. Australia & New Zealand
13.10.5. Rest of Asia Pacific
13.11. Market Attractiveness Analysis
13.11.1. By Product Type
13.11.2. By Test Type
13.11.3. By Indication
13.11.4. By End-user
13.11.5. By Country/Sub-region
14. Latin America GI Stool Testing Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2020-2034
14.2.1. Consumables
14.2.2. Analyzers
14.3. Market Attractiveness, by Product Type
14.4. Market Value Forecast, by Test Type, 2020-2034
14.4.1. Occult Blood Test
14.4.2. Ova and Parasites Test
14.4.3. Fecal Biomarkers Test
14.4.4. Others (Bacteria Test, etc.)
14.5. Market Attractiveness, by Test Type
14.6. Market Value Forecast, by Indication, 2020-2034
14.6.1. Infection
14.6.2. Inflammatory Bowel Disease
14.6.3. Gastroesophageal Reflux Disease
14.6.4. Cancer
14.6.5. Others (Poor Absorption Problems, etc.)
14.7. Market Attractiveness, by Indication
14.8. Market Value Forecast, by End-user, 2020-2034
14.8.1. Hospitals
14.8.2. Diagnostic Centers & laboratories
14.8.3. Academic Institutes
14.8.4. Research Centers & Organizations
14.8.5. Others (Homecare Settings, etc.)
14.9. Market Attractiveness, by End-user
14.10. Market Value Forecast, by Country/Sub-region, 2020-2034
14.10.1. Brazil
14.10.2. Mexico
14.10.3. Rest of Latin America
14.11. Market Attractiveness Analysis
14.11.1. By Product Type
14.11.2. By Test Type
14.11.3. By Indication
14.11.4. By End-user
14.11.5. By Country/Sub-region
15. Middle East & Africa GI Stool Testing Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Product Type, 2020-2034
15.2.1. Consumables
15.2.2. Analyzers
15.3. Market Attractiveness, by Product Type
15.4. Market Value Forecast, by Test Type, 2020-2034
15.4.1. Occult Blood Test
15.4.2. Ova and Parasites Test
15.4.3. Fecal Biomarkers Test
15.4.4. Others (Bacteria Test, etc.)
15.5. Market Attractiveness, by Test Type
15.6. Market Value Forecast, by Indication, 2020-2034
15.6.1. Infection
15.6.2. Inflammatory Bowel Disease
15.6.3. Gastroesophageal Reflux Disease
15.6.4. Cancer
15.6.5. Others (Poor Absorption Problems, etc.)
15.7. Market Attractiveness, by Indication
15.8. Market Value Forecast, by End-user, 2020-2034
15.8.1. Hospitals
15.8.2. Diagnostic Centers & laboratories
15.8.3. Academic Institutes
15.8.4. Research Centers & Organizations
15.8.5. Others (Homecare Settings, etc.)
15.9. Market Attractiveness, by End-user
15.10. Market Value Forecast, by Country/Sub-region, 2020-2034
15.10.1. GCC Countries
15.10.2. South Africa
15.10.3. Rest of Middle East & Africa
15.11. Market Attractiveness Analysis
15.11.1. By Product Type
15.11.2. By Test Type
15.11.3. By Indication
15.11.4. By End-user
15.11.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
16.2. Market Share Analysis, by Company (2023)
16.3. Company Profiles
16.3.1. Abbott Laboratories
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. Beckman Coulter, Inc.
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. Bio-Rad Laboratories
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. BioMérieux Inc.
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. Cardinal Health, Inc.
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. Cenogenics Corporation
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. Epitope Diagnostics, Inc.
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. ScheBo Biotech AG
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. Quest Diagnostics
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. Financial Overview
16.3.9.4. SWOT Analysis
16.3.9.5. Strategic Overview
16.3.10. Genova Diagnostics
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Product Portfolio
16.3.10.3. Financial Overview
16.3.10.4. SWOT Analysis
16.3.10.5. Strategic Overview
List of Tables
Table 01: Global GI Stool Testing Market Size (US$ Mn) Forecast, by Product Type, 2020-2034
Table 02: Global GI Stool Testing Market Size (US$ Mn) Forecast, by Test Type, 2020-2034
Table 03: Global GI Stool Testing Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 04: Global GI Stool Testing Market Size (US$ Mn) Forecast, by Indication, 2020-2034
Table 05: Global GI Stool Testing Market Size (US$ Mn) Forecast, by Region, 2020-2034
Table 06: North America GI Stool Testing Market Size (US$ Mn) Forecast, by Country, 2020-2034
Table 07: North America GI Stool Testing Market Size (US$ Mn) Forecast, by Product Type, 2020-2034
Table 08: North America GI Stool Testing Market Size (US$ Mn) Forecast, by Test Type, 2020-2034
Table 09: North America GI Stool Testing Market Size (US$ Mn) Forecast, by Indication, 2020-2034
Table 10: North America GI Stool Testing Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 11: Europe GI Stool Testing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 12: Europe GI Stool Testing Market Size (US$ Mn) Forecast, by Product Type, 2020-2034
Table 13: Europe GI Stool Testing Market Size (US$ Mn) Forecast, by Test Type, 2020-2034
Table 14: Europe GI Stool Testing Market Size (US$ Mn) Forecast, by Indication, 2020-2034
Table 15: Europe GI Stool Testing Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 16: Asia Pacific GI Stool Testing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 17: Asia Pacific GI Stool Testing Market Size (US$ Mn) Forecast, by Product Type, 2020-2034
Table 18: Asia Pacific GI Stool Testing Market Size (US$ Mn) Forecast, by Test Type, 2020-2034
Table 19: Asia Pacific GI Stool Testing Market Size (US$ Mn) Forecast, by Indication, 2020-2034
Table 20: Asia Pacific GI Stool Testing Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 21: Latin America GI Stool Testing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 22: Latin America GI Stool Testing Market Size (US$ Mn) Forecast, by Product Type, 2020-2034
Table 23: Latin America GI Stool Testing Market Size (US$ Mn) Forecast, by Test Type, 2020-2034
Table 24: Latin America GI Stool Testing Market Size (US$ Mn) Forecast, by Indication, 2020-2034
Table 25: Latin America GI Stool Testing Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 26: Middle East & Africa GI Stool Testing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 27: Middle East & Africa GI Stool Testing Market Size (US$ Mn) Forecast, by Product Type, 2020-2034
Table 28: Middle East & Africa GI Stool Testing Market Size (US$ Mn) Forecast, by Test Type, 2020-2034
Table 29: Middle East & Africa GI Stool Testing Market Size (US$ Mn) Forecast, by Indication, 2020-2034
Table 30: Middle East & Africa GI Stool Testing Market Size (US$ Mn) Forecast, by End-user, 2020-2034
List of Figures
Figure 01: Global GI Stool Testing Market Size (US$ Mn), by Region, 2023 and 2034
Figure 02: Global GI Stool Testing Market Revenue (US$ Mn), by Product Type, 2023
Figure 03: Global GI Stool Testing Market Value Share, by Product Type, 2023
Figure 04: Global GI Stool Testing Market Revenue (US$ Mn), by Test Type, 2023
Figure 05: Global GI Stool Testing Market Value Share, by Test Type, 2023
Figure 06: Global GI Stool Testing Market Revenue (US$ Mn), by Indication, 2023
Figure 07: Global GI Stool Testing Market Value Share, by Indication, 2023
Figure 08: Global GI Stool Testing Market Revenue (US$ Mn), by End-user, 2023
Figure 09: Global GI Stool Testing Market Value Share, by End-user, 2023
Figure 10: Global GI Stool Testing Market Value Share, by Region, 2023
Figure 11: Global GI Stool Testing Market Value (US$ Mn) Forecast, 2020-2034
Figure 12: Global GI Stool Testing Market Value Share Analysis, by Product Type, 2023 and 2034
Figure 13: Global GI Stool Testing Market Attractiveness Analysis, by Product Type, 2024-2034
Figure 14: Global GI Stool Testing Market Value Share Analysis, by Test Type, 2023 and 2034
Figure 15: Global GI Stool Testing Market Attractiveness Analysis, by Test Type, 2024-2034
Figure 16: Global GI Stool Testing Market Value Share Analysis, by Indication, 2023 and 2034
Figure 17: Global GI Stool Testing Market Attractiveness Analysis, by Indication, 2024-2034
Figure 18: Global GI Stool Testing Market Revenue (US$ Mn), by End-user, 2023
Figure 19: Global GI Stool Testing Market Value Share, by End-user, 2023
Figure 20: Global GI Stool Testing Market Value Share Analysis, by Region, 2023 and 2034
Figure 21: Global GI Stool Testing Market Attractiveness Analysis, by Region, 2024-2034
Figure 22: North America GI Stool Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 23: North America GI Stool Testing Market Attractiveness Analysis, by Country, 2024-2034
Figure 24: North America GI Stool Testing Market Value Share Analysis, by Country, 2023 and 2034
Figure 25: North America GI Stool Testing Market Value Share Analysis, by Product Type, 2023 and 2034
Figure 26: North America GI Stool Testing Market Value Share Analysis, by Test Type, 2023 and 2034
Figure 27: North America GI Stool Testing Market Value Share Analysis, by Indication, 2023 and 2034
Figure 28: North America GI Stool Testing Market Value Share Analysis, by End-user, 2023 and 2034
Figure 29: North America GI Stool Testing Market Attractiveness Analysis, by Product Type, 2024-2034
Figure 30: North America GI Stool Testing Market Attractiveness Analysis, by Test Type, 2024-2034
Figure 31: North America GI Stool Testing Market Attractiveness Analysis, by Indication, 2024-2034
Figure 32: North America GI Stool Testing Market Attractiveness Analysis, by End-user, 2024-2034
Figure 33: Europe GI Stool Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 34: Europe GI Stool Testing Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 35: Europe GI Stool Testing Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 36: Europe GI Stool Testing Market Value Share Analysis, by Product Type, 2023 and 2034
Figure 37: Europe GI Stool Testing Market Value Share Analysis, by Test Type, 2023 and 2034
Figure 38: Europe GI Stool Testing Market Value Share Analysis, by Indication, 2023 and 2034
Figure 39: Europe GI Stool Testing Market Value Share Analysis, by End-user, 2023 and 2034
Figure 40: Europe GI Stool Testing Market Attractiveness Analysis, by Product Type, 2024-2034
Figure 41: Europe GI Stool Testing Market Attractiveness Analysis, by Test Type, 2024-2034
Figure 42: Europe GI Stool Testing Market Attractiveness Analysis, by Indication, 2024-2034
Figure 43: Europe GI Stool Testing Market Attractiveness Analysis, by End-user, 2024-2034
Figure 44: Asia Pacific GI Stool Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 45: Asia Pacific GI Stool Testing Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 46: Asia Pacific GI Stool Testing Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 47: Asia Pacific GI Stool Testing Market Value Share Analysis, by Product Type, 2023 and 2034
Figure 48: Asia Pacific GI Stool Testing Market Value Share Analysis, by Test Type, 2023 and 2034
Figure 49: Asia Pacific GI Stool Testing Market Value Share Analysis, by Indication, 2023 and 2034
Figure 50: Asia Pacific GI Stool Testing Market Value Share Analysis, by End-user, 2023 and 2034
Figure 51: Asia Pacific GI Stool Testing Market Attractiveness Analysis, by Product Type, 2024-2034
Figure 52: Asia Pacific GI Stool Testing Market Attractiveness Analysis, by Test Type, 2024-2034
Figure 53: Asia Pacific GI Stool Testing Market Attractiveness Analysis, by Indication, 2024-2034
Figure 54: Asia Pacific GI Stool Testing Market Attractiveness Analysis, by End-user, 2023-2034
Figure 55: Latin America GI Stool Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 56: Latin America GI Stool Testing Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 57: Latin America GI Stool Testing Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 58: Latin America GI Stool Testing Market Value Share Analysis, by Product Type, 2023 and 2034
Figure 59: Latin America GI Stool Testing Market Value Share Analysis, by Test Type, 2023 and 2034
Figure 60: Latin America GI Stool Testing Market Value Share Analysis, by Indication, 2023 and 2034
Figure 61: Latin America GI Stool Testing Market Value Share Analysis, by End-user, 2023 and 2034
Figure 62: Latin America GI Stool Testing Market Attractiveness Analysis, by Product Type, 2024-2034
Figure 63: Latin America GI Stool Testing Market Attractiveness Analysis, by Test Type, 2024-2034
Figure 64: Latin America GI Stool Testing Market Attractiveness Analysis, by Indication, 2024-2034
Figure 65: Latin America GI Stool Testing Market Attractiveness Analysis, by End-user, 2024-2034
Figure 66: Middle East & Africa GI Stool Testing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 67: Middle East & Africa GI Stool Testing Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 68: Middle East & Africa GI Stool Testing Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 69: Middle East & Africa GI Stool Testing Market Value Share Analysis, by Product Type, 2023 and 2034
Figure 70: Middle East & Africa GI Stool Testing Market Value Share Analysis, by Test Type, 2023 and 2034
Figure 71: Middle East & Africa GI Stool Testing Market Value Share Analysis, by Indication, 2023 and 2034
Figure 72: Middle East & Africa GI Stool Testing Market Value Share Analysis, by End-user, 2023 and 2034
Figure 73: Middle East & Africa GI Stool Testing Market Attractiveness Analysis, by Product Type, 2024-2034
Figure 74: Middle East & Africa GI Stool Testing Market Attractiveness Analysis, by Test Type, 2024-2034
Figure 75: Middle East & Africa GI Stool Testing Market Attractiveness Analysis, by Indication, 2024-2034
Figure 76: Middle East & Africa GI Stool Testing Market Attractiveness Analysis, by End-user, 2024-2034
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
GI Stool Testing Market
